J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaefer, E. J.
Right arrow Articles by Lindgren, F. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaefer, E. J.
Right arrow Articles by Lindgren, F. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 26, 1089-1101, Copyright © 1985 by Lipid Research, Inc.


ARTICLES

Familial apolipoprotein A-I and C-III deficiency, variant II

EJ Schaefer, JM Ordovas, SW Law, G Ghiselli, ML Kashyap, LS Srivastava, WH Heaton, JJ Albers, WE Connor and FT Lindgren

The biochemical, clinical, and genetic features were examined in the proband (homozygote) and heterozygotes (n = 17) affected with familial apolipoprotein A-I and C-III deficiency, variant II (previously described as apolipoprotein A-I absence). The proband was a 45-year-old white female with mild corneal opacification and significant three- vessel coronary artery disease (CAD), who died shortly after bypass surgery. Autopsy findings included significant atherosclerosis in the coronary and pulmonary arteries and the abdominal aorta as well as extracellular stromal lipid deposition in the cornea. No reticuloendothelial lipid deposits in the liver, bone marrow, or spleen were noted (unlike Tangier disease). Laboratory features included marked high density lipoprotein (HDL) deficiency and undetectable plasma apolipoproteins (apo) A-I and C-III. The percentage of plasma cholesterol in the unesterified form was normal at 30%. The activity and mass of lecithin:cholesterol acyltransferase (LCAT) were 42% and 36% of normal, respectively, and the cholesterol esterification rate was 43% of normal. Deficiencies of plasma vitamin E and essential fatty acid (linoleic, C18:2) were also noted. Evaluation of plasma lipoproteins and apolipoproteins in 37 kindred members revealed 17 heterozygotes with HDL cholesterol values below the 10th percentile of normal. Of these, all had apoA-I levels more than one standard deviation below the normal mean, and 37.5% had a similar decrease in apoC-III values. Mean (+/- SD) plasma HDL cholesterol, apoA-I, and apoC- III values (mg/dl) in heterozygotes were 54.0%, 62.4%, and 79.2% of normal, respectively. No evidence of CAD was observed in 10 heterozygotes 40 years of age or less; however, CAD was detected in 3 of 7 heterozygotes over 40 years of age, one of whom died at age 56 years of complications of myocardial infarction and stroke. The inheritance pattern in this kindred was autosomal codominant. ApoA-I isolated from a heterozygote had an isoelectric focusing pattern and amino acid composition similar to normal. Utilizing DNA isolated from two obligate heterozygotes, no abnormalities in the apoA-I or apoC-III genes were detected by Southern blot analysis utilizing specific probes following restriction enzyme digestion. The data indicate that familial apolipoprotein A-I and C-III deficiency, variant II, is similar to variant I (described by Norum et al. 1982. N. Engl. J. Med. 306: 1513- 1519), but differs at the clinical level (lack of xanthomas), the biochemical level (lack of detectable apoA-I, lower apoA-II level), and at the gene level.(ABSTRACT TRUNCATED AT 400 WORDS)
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al.
Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency
J. Lipid Res., February 1, 2008; 49(2): 349 - 357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. J Schaefer
Lipoproteins, nutrition, and heart disease
Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. G. Sorci-Thomas, M. Thomas, L. Curtiss, and M. Landrum
Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Delta 6 and Wild-type ApoA-I in Transgenic Mice
J. Biol. Chem., April 14, 2000; 275(16): 12156 - 12163.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. C. Jong, M. H. Hofker, and L. M. Havekes
Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3
Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 472 - 484.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Moriyama, J. Sasaki, Y. Takada, A. Matsunaga, J. Fukui, J. J. Albers, and K. Arakawa
A Cysteine-Containing Truncated Apo A-I Variant Associated With HDL Deficiency
Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1416 - 1423.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. S. Ng, C. Vezina, T. S. Wolever, A. Kuksis, R. A. Hegele, and P. W. Connelly
Apolipoprotein A-I Deficiency : Biochemical and Metabolic Characteristics
Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2157 - 2164.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Takata, K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa
A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1866 - 1874.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Marcil, B. Boucher, L. Krimbou, B. C. Solymoss, J. Davignon, J. Frohlich, and J. Genest Jr
Severe Familial HDL Deficiency in French-Canadian Kindreds : Clinical, Biochemical, and Molecular Characterization
Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1015 - 1024.
[Abstract] [Full Text]


Home page
ScienceHome page
R. Prioli, J. Ordovas, I Rosenberg, E. Schaefer, and M. Pereira
Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein
Science, December 4, 1987; 238(4832): 1417 - 1419.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1985 by the American Society for Biochemistry and Molecular Biology.